Distinctive symptoms
Register , to see more distinctive signs of diseases and studies 95% 44%
Register , to see more distinctive signs of diseases and studies — 100%
uterine tumor
100%
54%
cervical canal stenosis —
95%
benign neoplasms
63%
37%
spotting from the uterus —
75%
multiple fibroids
21%
—
vaginal polyp —
75%
monthly abundant and prolonged
8%
—
vaginal septum —
75%
very abundant monthly
8%
—
consequences of abortion —
67%
cystic mastopathy
7%
—
intrauterine septum —
66%
mastopathy
7%
—
abortions —
65%
diffuse mastopathy
7%
—
cause consequences of abortion —
63%
fibrous mastopathy
7%
—
impaired uterine function
2%
64%
endometrioid ovarian cyst
6%
—
the emerging myomatous node
1%
62%
endometriosis
6%
—
uterine polyps
4%
64%
endometrial hyperplasia
6%
—
anomalies of the female genital organs —
59%
dysfunctional uterine bleeding
5%
—
cervical polyp —
58%
uterine cyst
4%
—
weakness of labor activity —
57%
growth of uterine fibroids
4%
—
female pelvic organs
2%
57%
ovarian cysts
4%
—
scar on the uterus —
55%
bleeding uterine
4%
—
ascherman syndrome
1%
55%
desire for fresh air
3%
—
body of uterus is soft —
51%
profuse uterine bleeding
3%
—
lochiometer —
51%
infertility female
3%
—
cervical canal atresia —
51%
hot rush with sweating
3%
—
cramps in uterus —
51%
papillomas on the neck
3%
—
tame child —
51%
monthly painful
3%
—
benign vaginal tumors
1%
51%
hyperplasia of endometrium of uterus
3%
—
benign tumors of the pharynx —
49%
menstruation irregular
3%
—
heaviness in the uterus —
49%
adenomyosis
3%
—
removal of the uterine body
1%
50%
menopause
3%
—
uterine fibroids
2%
51%
thyroid nodes
3%
—
blood diseases
2%
50%
menopause sweating
3%
—
polyps
4%
52%
patient's condition
2%
—
heaviness in the lower abdomen —
48%
painful swelling
2%
—
feeling of heaviness in the lower abdomen —
48%
appendages of the uterus
2%
—
on palpation the uterus painful —
48%
responsible
2%
—
pain in the uterus
2%
50%
enlargement of the thyroid gland
2%
—
secondary amenorrhea —
46%
hot flashes
2%
—
consequences of childbirth
0%
46%
menopause diseases
2%
—
cramping pain in the lower abdomen —
46%
clots menstruation
2%
—
uterine atresia —
46%
guilt
2%
—
pharyngeal cancer —
46%
miscarriage
2%
—
lower abdominal pain in women
1%
46%
chilly
2%
—
lower abdominal pain
1%
45%
monthly prolonged
2%
—
vaginal atresia —
44%
necrosis of the myomatous node
2%
—
menstruation disorder
1%
44%
uterine fibroids during pregnancy
2%
—
cervical canal polyps —
42%
cervical fibroids
2%
44%
endometrial cancer —
42%
consequences of taking medications
1%
43%
hemorrhagic disease of newborns —
41%
vacuum —
41%
submucous uterine fibroids
2%
42%
cervical cancer —
38%
postpartum contractions —
38%
spastic abdominal pain —
38%
abnormalities of uterine development —
38%
flies in front of the eyes —
37%
stomach cramping pain —
37%
endometrial polyps
3%
39%
spasm —
36%
scarring —
36%
discharge from the genital tract —
36%
abdominal pain
1%
36%
uterine cancer
1%
36%
severe dizziness —
35%
enlargement of the uterus
2%
36%
heaviness in the abdomen
1%
35%
feeling of heaviness in the stomach
1%
35%
birth trauma —
34%
frequent dizziness —
33%
traumatic shock —
33%
pulse is strong —
32%
effects of radiation —
32%
large fruit —
32%
pain in the vagina
1%
33%
trauma —
32%
lack of menstruation
1%
33%
complications of childbirth —
31%
heartbeat in the head —
31%
spasmodic pain —
31%
sluggish baby —
31%
sudden pain —
30%
arterial bleeding —
30%
large child —
29%
shock states of various genesis —
29%
effects of shock —
29%
chills —
28%
history of surgery
1%
29%
lymphosarcoma
1%
28%
conservative
1%
28%
dizziness —
27%
radiation therapy —
27%
metastases —
27%
pain when touched —
27%
radiation damage —
26%
tachycardia —
26%
presses —
25%
palpitations —
25%
weakness after illness —
25%
consequences of injuries —
25%
oncology in the anamnesis
2%
27%
hypotension
2%
26%
cancer
0%
24%
acute pain
1%
24%
onset of illness —
23%
childhood diseases —
23%
impaired arterial function
1%
23%
anemia
3%
25%
pregnancy
2%
24%
drug disease
1%
23%
increased
1%
21%
consequences of medical abortion —
20%
inflammation
1%
21%
bleeding
5%
24%
oncology
29%
38%